Filtered By:
Countries: USA Health

This page shows you your search results in order of date. This is page number 17.

Order by Relevance | Date

Total 380 results found since Jan 2013.

New Innovation to Address System Overload by Systemizing the Field Triage and Treatment of Non-Emergent Patients
Introductory Note from JEMS Editor Emeritus A.J. Heightman, MPA, EMT-P JEMS has prided itself on introducing countless groundbreaking concepts and innovations to the EMS community since its inception in 1980. As an example, in May 1980, JEMS introduced Jack Stout’s Public Utility Model and System Status management which changed the way many EMS Systems operated. His concepts introduced new ways to maximize resources and revenue through changes in the deployment of crews and resources. In Feb. of 1981, Dr. Jeff Clawson’s dispatch priority training and the Medical Priority Dispatch System (MPDS); the impact and des...
Source: JEMS Administration and Leadership - January 18, 2021 Category: Emergency Medicine Authors: Marc Eckstein, MD, MPH Tags: Administration and Leadership Communications & Dispatch Exclusives California EMS Prehospital Telemedicine Source Type: news

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
This report summarizes the clinical and epidemiologic characteristics of case reports of allergic reactions, including anaphylaxis and nonanaphylaxis allergic reactions, after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine during December 14-23, 2020, in the United States. CDC has issued updated interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States (4) and interim considerations for preparing for the potential management of anaphylaxis (5). In addition to screening for contraindications and precautions before administering COVID-19 vaccines, vaccine locat...
Source: MMWR Morb Mortal Wkl... - January 15, 2021 Category: Epidemiology Authors: CDC COVID-19 Response Team, Food and Drug Administration Tags: MMWR Morb Mortal Wkly Rep Source Type: research

Atopic Dermatitis in the Pediatric Population: A Cross-sectional, International, Epidemiologic Study.
CONCLUSION: This global survey in 18 countries showed that AD affects a substantial proportion of the pediatric population. Although prevalence and severity varied across age groups and countries, <15% had severe AD. PMID: 33421555 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - January 6, 2021 Category: Allergy & Immunology Authors: Silverberg JI, Barbarot S, Gadkari A, Simpson EL, Weidinger S, Mina-Osorio P, Rossi AB, Brignoli L, Saba G, Guillemin I, Fenton MC, Auziere S, Eckert L Tags: Ann Allergy Asthma Immunol Source Type: research

Model of Walnut Allergy in CC027/GeniUnc Mice Recapitulates Key Features of Human Disease.
Authors: Smeekens JM, Orgel KA, Kesselring J, Bagley K, Kulis MD Abstract Tree nut allergies affect 1% of the United States population, are often severe in nature and rarely outgrown. Despite the severity and prevalence, there are no FDA-approved treatments for tree nut allergy. Development of a therapeutic would be expedited by having a mouse model that mimics the human disease. We utilized the CC027/GeniUnc mouse strain, which was previously identified as an orally reactive model of peanut allergy, to develop a model of walnut allergy. Mice were sensitized with walnut and cholera toxin for 4 weeks and subsequentl...
Source: The Yale Journal of Biology and Medicine - January 1, 2021 Category: Universities & Medical Training Tags: Yale J Biol Med Source Type: research

European Union Greenlights BioNTech-Pfizer COVID-19 Vaccine After Agency Gives Safety Approval
(AMSTERDAM) — The European Union on Monday gave official approval for the coronavirus vaccine developed by BioNTech and Pfizer to be used across the 27-nation bloc, raising hopes that countries can begin administering the first shots to their citizens shortly after Christmas. The EU’s executive commission gave the green light just hours after the European Medicines Agency said the vaccine meets safety and quality standards. Brussels had been expected to take two or three days to endorse the market authorization move. “As we have promised, this vaccine will be available for all EU countries at the same tim...
Source: TIME: Health - December 21, 2020 Category: Consumer Health News Authors: ALEKSANDAR FURTULA and FRANK JORDANS / AP Tags: Uncategorized COVID-19 wire Source Type: news

Moderna ’s COVID-19 Vaccine Becomes Second Shot Authorized for Emergency Use in the U.S.
The U.S. now has two COVID-19 vaccines that are safe and effective enough for the public. On Dec. 18, the Food and Drug Administration issued an emergency use authorization (EUA) for a COVID-19 vaccine made by Moderna, a biotech company based in Massachusetts. The decision followed an overwhelming 20 to zero vote, with one abstention, in favor or authorizing the vaccine by an FDA vaccine advisory committee on Dec. 17. “This evening the FDA granted the second emergency use authorization for a COVID-19 vaccine,” Dr. Stephen Hahn, commissioner of the FDA, said during a media briefing announcing the decision. &ld...
Source: TIME: Health - December 18, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this management. ...
Source: JEMS Patient Care - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news